Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genesis Botanicals is an Australian-based healthcare company that specializes in the development and production of high-quality botanical extracts and medicinal cannabis products. The company is recognized for its utilization of spagyric extraction methods, which are designed to preserve the full chemical and mineral profile of the source plants to enhance therapeutic efficacy and bioavailability. Their product line primarily targets the endocannabinoid system, offering organic, lab-tested solutions for conditions such as chronic pain, anxiety, and sleep disorders. Genesis Botanicals bridges the gap between traditional herbalism and modern clinical standards by providing standardized tinctures and oils to healthcare practitioners and consumers. The company emphasizes sustainable sourcing and rigorous quality control to ensure the purity of its plant-based medicines. It operates as a key provider in the Oceania region for specialized herbal therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genesis Botanicals.